Hazard Anticipation Program for Motor Vehicle Accidents
(HazAPP Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to help parents teach their teen drivers to better spot road hazards. Half of the parents will use a special online program, the Hazard Anticipation Program for Parents of Teen Drivers, designed to enhance their guidance skills, while the other half will not. Researchers will then compare how well parents teach their teens in both real and simulated driving environments. Parents with teens aged 14-17 who are learning to drive may be a good fit for this study. As an unphased trial, this study offers a unique opportunity for parents to improve their teaching skills and contribute to safer driving practices for teens.
Will I have to stop taking my current medications?
The trial information does not specify whether participants need to stop taking their current medications.
What prior data suggests that this program is safe for improving teen driving skills?
Research has not provided specific safety data for the Hazard Anticipation Program for Motor Vehicle Accidents. However, similar programs involving parental assistance for teen drivers have generally proven safe. These programs instruct parents on helping teens identify and manage potential road hazards.
The program in this study is educational, featuring online training and video sessions. With no physical or medical treatment involved, the risk of negative effects remains very low. Participants learn and practice safer driving habits, which are unlikely to cause harm.12345Why are researchers excited about this trial?
Researchers are excited about the Hazard Anticipation Program because it offers a proactive approach by involving parents directly in their teen's driver education. Unlike traditional driver education programs that focus primarily on teens alone, this program empowers parents with web-based training to help their teens identify potential road hazards. This unique parent-teen collaboration, which includes practicing with video simulations, aims to enhance hazard awareness in real-world scenarios. By providing flexible, self-paced learning that fits into busy family schedules, the program could significantly improve teen driver safety.
What evidence suggests that the Hazard Anticipation Program is effective for improving teen drivers' hazard anticipation skills?
Research shows that training programs can help young drivers spot potential dangers on the road. Studies have found that after participating in these programs, young drivers improve at noticing hazards. However, while these programs enhance skills, they have not yet directly reduced crash rates. In this trial, the Hazard Anticipation Program for Parents of Teen Drivers aims to boost these skills by guiding parents on how to teach their teens effectively. Participants in this arm of the trial will engage in a web-based training that provides a practical way for parents and teens to learn these safety skills together.23567
Are You a Good Fit for This Trial?
This trial is for parents who are the main driving instructors for their teens aged 14-17, who are in the learner phase of getting a driver's license. It aims to improve how parents teach hazard anticipation skills during supervised driving.Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Intervention
Parents in the intervention group complete a web-based training program to improve hazard anticipation skills over a two-week period.
Application
Parents apply the training in real-world driving sessions with their teens, completing a minimum of 5 recorded drives.
Simulator Assessment
Teens and parents complete a drive in a simulator to assess hazard anticipation and driving performance.
Follow-up
Participants are monitored for safety and effectiveness after the intervention.
What Are the Treatments Tested in This Trial?
Interventions
- Hazard Anticipation Program for Parents of Teen Drivers
Find a Clinic Near You
Who Is Running the Clinical Trial?
Elizabeth O'Neal
Lead Sponsor